Upcoming FDA decision · January 20, 2027
OPX-102 PDUFA date: FDA decision expected January 20, 2027
159 days to goOpus Genetics, Inc. (IRD) →
The FDA is expected to decide on OPX-102 from Opus Genetics, Inc. in Achromatopsia by the PDUFA target action date of January 20, 2027. For Achromatopsia. NDA filing. Extracted from SEC filing: 8-K
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
January 20
Target action date
NDA
Stage
Detected
Date confidence
—
FDA designations